Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences GAAP operating margin: 34.0% in FY2025, up 28.2 pts from a year earlier.
Latest, FY2025
34.0%
Period ended Dec 31, 2025
Change on a year earlier
+28.2 pts
5.8% in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Where the FY2025 figure comes from
“|| GAAP operating margin | 25.0 | % | 32.4 | % | 34.0 | % | 5.8 | %”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP operating margin (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34.0% | +28.2 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 5.8% | -22.2 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 28.0% | +1.1 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 26.9% | -9.4 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 36.3% | +19.8 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 16.5% | -2.6 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
| FY2019 | Dec 31, 2019 | 19.1% | -18.0 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2021-02-04) ↗ |
| FY2018 | Dec 31, 2018 | 37.1% | -17.0 pts | Form 8-K (exhibit991earningspres.htm, filed 2020-02-04) ↗ |
| FY2017 | Dec 31, 2017 | 54.1% | -3.9 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2019-02-04) ↗ |
| FY2016 | Dec 31, 2016 | 58.0% | – | Form 8-K (gildq42017exh991.htm, filed 2018-02-06) ↗ |
Cite this data
StockData. (2026). Gilead Sciences GAAP operating margin (%), annual FY2016–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/gaap-op-margin-pct
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.